Latest Licensing News

Verity Resources Limited has announced a pro-rata entitlement issue to raise up to $2.05 million, partially underwritten by entities linked to its directors. The capital raise aims to fund exploration and technical studies across its key projects, including the Monument Gold Project.

WT Financial Group has delivered a robust half-year performance with underlying net revenue up 19.3% and net profit after tax rising 14.4%, driven by adviser productivity and strategic investments.

Aguia Resources is poised to commence production at its Tres Estradas phosphate mine with infrastructure nearly complete and key licenses expected imminently. Meanwhile, exploration at the nearby Passo Feio project reveals promising phosphate grades, underpinning a strong market outlook amid global supply constraints.

ASX Limited has posted a solid 8.3% increase in net profit for the half-year ending December 2025, while announcing a reduced dividend payout and the planned departure of its CEO. The company is navigating regulatory scrutiny and investing heavily in technology upgrades.

Viva Leisure has reported a robust half-year performance with underlying NPAT up 46.8% and revenue climbing to $116.5 million, driven by strong organic membership growth and a booming technology segment.

Viva Leisure Limited has reported a robust half-year performance for the period ending 31 December 2025, with revenues climbing 17.6% and profit after tax soaring by 167.8%. The company’s strategic focus on franchise expansion and technology innovation is driving growth.

Viva Leisure has reported a striking 168% jump in net profit after tax for HY2026, driven by strong revenue growth and a booming technology segment. The company’s strategic shift towards technology and network optimisation is paying off, with cash flow and membership numbers also on the rise.

Critical Resources Limited has launched a six-month evaluation program in partnership with the South Dakota School of Mines & Technology to develop next-generation solid-state lithium-ion battery materials, aiming to reduce technical risks and accelerate prototype development.

TG Metals has lodged a provisional patent application for a new technology that significantly improves lithium recovery and concentrate quality at its Burmeister deposit in Western Australia.

PYC Therapeutics has initiated a substantial capital raising effort, aiming to secure up to A$653 million to propel its four RNA therapeutic candidates through critical clinical milestones. The retail entitlement offer opens today, following a successful institutional placement.

Dexus Convenience Retail REIT (DXC) reports solid HY26 results with strong income growth and high occupancy, while advancing strategic development projects to enhance its metro and highway retail footprint.

Paradigm Biopharmaceuticals has entered a binding agreement with AVet Health to co-develop and license a novel oral therapy for veterinary osteoarthritis in Australia and New Zealand, unlocking new market potential while advancing its human clinical trials.